The impact of concomitant administration of vanadium and insulin on endothelial dysfunction markers (PAI-1 and ET-1) in type 1 diabetic rats

References

• Aburawi, E.H., et al., 2016. Subclinical inflammation and endothelial dysfunction in young patients with diabetes: a study from United Arab Emirates. PLoS one, 11 (7), e0159808.
   PubMed Web of Science ®Google Scholar
• Al Lafi, S.M., et al., 2013. Aliskiren, exendin-4, and insulin: their impact on endothelin receptor subtype(s) regulation/binding in type 1 diabetic rat hearts. Canadian journal of physiology and pharmacology, 91 (10), 830–838.
   PubMed Web of Science ®Google Scholar
• Arosio, E., Minuz, P., and Prior, M., 1999. Endothelial function and the microcirculation in diabetes mellitus. Annali Italiani di medicina interna, 14 (2), 106–113.
   Google Scholar
• Aso, Y., et al., 2001. Relationship between plasma soluble thrombomodulin levels and insulin resistance syndrome in type 2 diabetes: a comparison with von Willebrand factor. Experimental and clinical endocrinology and diabetes, 109 (04), 210–216.
   PubMedGoogle Scholar
• Byrne, A.R. and Kosta, L., 1978. Vanadium in foods and in human body fluids and tissues. The science of the total environment, 10 (1), 17–30.
   PubMed Web of Science ®Google Scholar
• Cong, X.Q., et al., 2016. Bis (maltolato) oxovanadium (IV)(BMOV) attenuates apoptosis in high glucose-treated cardiac cells and diabetic rat hearts by regulating the unfolded protein responses (UPRs). Biological trace element research, 173 (2), 390–398.
   PubMed Web of Science ®Google Scholar
• Crutchley, D.J., et al., 1989. Levels of three hemostatic factors in relation to serum lipids. Monocyte procoagulant activity, tissue plasminogen activator, and type-1 plasminogen activator inhibitor. Arteriosclerosis, 9 (6), 934–939.
   PubMedGoogle Scholar
• Datta, S.R., et al., 1997. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell, 91 (2), 231–241.
   PubMed Web of Science ®Google Scholar
• Forstermann, U. and Munzel, T., 2006. Endothelial nitric oxide synthase in vascular disease: from marvel to menace. Circulation, 113 (13), 1708–1714.
   PubMed Web of Science ®Google Scholar
• García-Vicente, S., et al., 2007. Oral insulin-mimetic compounds that act independently of insulin. Diabetes, 56 (2), 486–493.
   PubMed Web of Science ®Google Scholar
• Gonnelli, S., et al., 2011. The role of osteoprotegerin, rank-ligand, matrix-gla protein and C-type natriuretic peptide on the carotid atherosclerosis in normal and diabetic subjects. Bone, 48, S201.
   Web of Science ®Google Scholar
• Gros, R., Borkowski, K.R., and Feldman, R.D., 1994. Human insulin-mediated enhancement of vascular beta-adrenergic responsiveness. Hypertension (Dallas, TX: 1979), 23 (5), 551–555.
   PubMed Web of Science ®Google Scholar
• Huo, Y., and Ley, K., 2001. Adhesion molecules and atherogenesis. Acta physiologica scandinavica, 173 (1), 35–43.
   PubMedGoogle Scholar
• Huyer, G., et al., 1997. Mechanism of inhibition of protein-tyrosine phosphatases by vanadate and pervanadate. The journal of biological chemistry, 272 (2), 843–851.
   PubMed Web of Science ®Google Scholar
• Iglesias-González, T., et al., 2012. Absorption, transport and insulin-mimetic properties of bis(maltolato)oxovanadium (IV) in streptozotocin-induced hyperglycemic rats by integrated mass spectrometric techniques. Analytical and bioanalytical chemistry, 402 (1), 277–285.
   PubMed Web of Science ®Google Scholar
• Jenkins, A.J., et al., 2010. Increased serum kallistatin levels in type 1 diabetes patients with vascular complications. Journal of angiogenesis research, 2 (1), 19.
   PubMedGoogle Scholar
• Jialal, I., et al., 2010. Decreased number and impaired functionality of endothelial progenitor cells in subjects with metabolic syndrome: implications for increased cardiovascular risk. Atherosclerosis, 211 (1), 297–302.
   PubMed Web of Science ®Google Scholar
• Kakizawa, H., et al., 2004. The relationship between glycemic control and plasma vascular endothelial growth factor and endothelin-1 concentration in diabetic patients. Metabolism: clinical and experimental, 53 (5), 550–555.
   PubMed Web of Science ®Google Scholar
• Kakkar, P., Das, B., and Viswanathan, P., 1984. A modified spectrophotometric assay of superoxide dismutase. Indian J Biochem Biophys, 21 (2), 130–132.
   PubMed Web of Science ®Google Scholar
• Kalani, M., 2008. The importance of endothelin-1 for microvascular dysfunction in diabetes. Vascular health and risk management, 4 (5), 1061–1068.
   PubMedGoogle Scholar
• Kawamura, M., et al., 1992. Increased plasma endothelin in NIDDM patients with retinopathy. Diabetes care, 15 (10), 1396–1397.
   PubMed Web of Science ®Google Scholar
• Kobayashi, Y., et al., 1990. The correlation between the activity of tissue plasminogen activator (TPA), levels of tissue plasminogen activator inhibitor (PAI-1) antigen and serum lipids in healthy subjects. Nihon Ronen Igakkai Zasshi. Japanese journal of geriatrics, 27 (5), 578–583.
   PubMedGoogle Scholar
• Madan, R., et al., 2010. Coagulation profile in diabetes and its association with diabetic microvascular complications. The journal of the association of physicians of India, 58, 481–484.
   PubMedGoogle Scholar
• Metelo, A.M., et al., 2012. VO (dmpp) 2 normalizes pre-diabetic parameters as assessed by in vivo magnetic resonance imaging and spectroscopy. Journal of inorganic biochemistry, 115, 44–49.
   PubMed Web of Science ®Google Scholar
• Panchal, S.K., Wanyonyi, S., and Brown, L., 2017. Selenium, vanadium, and chromium as micronutrients to improve metabolic syndrome. Current hypertension reports, 19 (3), 10.
   PubMed Web of Science ®Google Scholar
• Shachor-Meyouhas, Y., Pillar, G., and Shehadeh, N., 2007. Uncontrolled type 1 diabetes mellitus and endothelial dysfunction in adolescents. IMAJ, 9 (9), 637–640.
   Google Scholar
• Shioda, N., et al., 2007. Activation of phosphatidylinositol 3-kinase/protein kinase B pathway by a vanadyl compound mediates its neuroprotective effect in mouse brain ischemia. Neuroscience, 148 (1), 221–229.
   PubMed Web of Science ®Google Scholar
• Shurtz-Swirski, R., et al., 2001. Involvement of peripheral polymorphonuclear leukocytes in oxidative stress and inflammation in type 2 diabetic patients. Diabetes care, 24 (1), 104–110.
   PubMed Web of Science ®Google Scholar
• Soltesz, G., Patterson, C., and Dahlquist, G., 2009. Diabetes in the young: a global perspective. IDF diabetes atlas. Brussels: International Diabetes Federation.
   Google Scholar
• Stankiewicz, P.J., et al., 1987. 2,3-Diphosphoglycerate phosphatase activity of phosphoglycerate mutase: stimulation by vanadate and phosphate. Biochemistry, 26 (5), 1264–1269.
   PubMed Web of Science ®Google Scholar
• Tsiani, E., et al., 1998. Tyrosine phosphatase inhibitors, vanadate and pervanadate, stimulate glucose transport and GLUT translocation in muscle cells by a mechanism independent of phosphatidylinositol 3-kinase and protein kinase C. Diabetes, 47 (11), 1676–1686.
   PubMed Web of Science ®Google Scholar
• Umpaichitra, V., Hussain, M.M., and Castells, S., 2005. Plasminogen activator inhibitor-1 and tissue-plasminogen activator in minority adolescents with type 2 diabetes and obesity. Pediatric research, 58 (3), 483–487.
   PubMed Web of Science ®Google Scholar
• van den Oever, I.A., et al., 2010. Endothelial dysfunction, inflammation, and apoptosis in diabetes mellitus. Mediators of inflammation, 2010, 792393.
   PubMed Web of Science ®Google Scholar
• Wiernsperger, N. and Rapin, J., 2010. Trace elements in glucometabolic disorders: an update. Diabetology & metabolic syndrome, 2 (1), 70.
   PubMedGoogle Scholar
• Wu, S., et al., 2012. Intra-individual variability of high-sensitivity C-reactive protein in Chinese general population. International journal of cardiology, 157 (1), 75–79.
   PubMed Web of Science ®Google Scholar
• Yuen, V.G., McNeill, J., and Orvig, C., 1995. Comparison of the glucose-lowering properties of vanadyl sulfate and bis(maltolato)oxovanadium(IV) following acute and chronic administration. Canadian journal of physiology and pharmacology, 73 (1), 55–64.
   PubMed Web of Science ®Google Scholar
• Zampella, G., et al., 2006. Insight into the catalytic mechanism of vanadium haloperoxidases. DFT investigation of vanadium cofactor reactivity. Inorganic chemistry, 45 (18), 7133–7143.
   PubMed Web of Science ®Google Scholar